 CHICAGO--BUSINESS WIRE--Xeris Pharmaceuticals, Inc. Nasdaq: XERS, a specialty pharmaceutical company leveraging its novel formulation technology platforms to develop and commercialize ready-to-use injectable and infusible drug formulations, today announced that the Company will release its fourth quarter and full-year 2020 financial results before the open of the U.S. financial markets on Tuesday, March 9, 2021. Management will host a conference call and webcast at 8:30 a.m. ET that day to 